Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Melanoma Research|December 3, 2009
The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanomaChan Yoon, Nicholas E Papadopoulos, Luis H Camacho, et al.Clinical Genitourinary Cancer|June 25, 2011
Retrospective analysis of satraplatin in patients with metastatic urothelial cancer refractory to standard platinum-based chemotherapyMatthew D Galsky, Sonia Seng, Luis H Camacho, et al.Clinical Colorectal Cancer|January 7, 2011
Exploratory study of hepatic arterial infusion oxaliplatin with systemic 5-fluorouracil/bevacizumab in patients with refractory solid tumor and extensive liver metastasesLuis H Camacho, Sheila Garcia, Amar M Panchal, et al.Targeted Oncology|October 29, 2015
Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced CancerJohn Sarantopoulos, Monica M Mita, Michael J Birrer, et al.Annals of Surgical Oncology|December 4, 2004
A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanomaMatthew T Ballo, Gunar K Zagars, Jeffrey E Gershenwald, et al.The Oncologist|March 18, 2016
Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid TumorsAnthony J Olszanski, David C Smith, Luis H Camacho, et al.Cancer|April 3, 2008
Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaireJanice N Cormier, Merrick I Ross, Jeffrey E Gershenwald, et al.Cancer|March 6, 2008
Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III diseaseDaniel A Anaya, Yan Xing, Lei Feng, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
Phase I/II trial of tremelimumab in patients with metastatic melanomaLuis H Camacho, Scott Antonia, Jeffrey Sosman, et al.Cancer|April 15, 2006
Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanomaJames M Reuben, Bang-Ning Lee, Changping Li, et al.Pageof 4